Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1995-06-05
1996-10-08
Richter, Johann
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
546 85, 546 86, 546 87, A61K 3144, C07D47104
Patent
active
055631479
ABSTRACT:
This invention provides novel, optionally substituted tetrahydropyridoindoles which are useful serotonergic agents for the treatment of central nervous system disorders.
REFERENCES:
patent: 4035369 (1977-07-01), Vandenberk et al.
patent: 4254127 (1981-03-01), Vandenberk et al.
patent: 4432978 (1984-02-01), Welch et al.
patent: 4547507 (1985-10-01), Rowlands et al.
patent: 4680296 (1987-07-01), Manoury et al.
patent: 4789676 (1988-12-01), Hilbert et al.
patent: 5434148 (1995-07-01), Yamada et al.
Gueremy, et al., Naphthosultam derivatives as serotonin antagonists, Derwent WPI abstract (91-339733/46) 1991.
Gallagher Peter T.
Gilmore Jeremy
Miles Martin V.
Owton William M.
Smith Colin W.
Boone David E.
Eli Lilly and Company
Jones Joseph J.
Richter Johann
Stockton Laura L.
LandOfFree
Serotonerbic tetrahydropyridoindoles does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Serotonerbic tetrahydropyridoindoles, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Serotonerbic tetrahydropyridoindoles will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-57516